CLDX
Celldex TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CLDX vs peer average
51/100
CLDX vs. peer average (C vs. C)
Grade spread
A 3 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANIP is the first available peer comparator.
ANI Pharmaceuticals is a loose comp given its more commercial profile, but the contrast highlights that CLDX still trades mainly on binary development milestones rather than operating leverage.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLDX
Celldex Therapeutics
ANIP
ANI
Grade
C
A
Momentum
19
59
Value
41
68
Sentiment
73
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ANIP
CLDX / ANIP
Grade Position
In line
CLDX vs. peer average (C vs. C)
51/100
Momentum
19
ANIPValue
41
ANIPSentiment
73
CLDXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLDX
ANIP is the first peer returned for this comparison set.